Clinical Trial Update: Pixantrone, Cytarabine, Methylprednisolone, and Cisplatin in Treating Patients With Aggressive Non-Hodgkin's Lymphoma in First Relapse [Phase 2]

View source ↗

Summary

This is a Phase 2 trial evaluating a four-drug regimen (pixantrone, cytarabine, methylprednisolone, and cisplatin) for aggressive non-Hodgkin's lymphoma at firs…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• CISPLATIN (cisplatin)
• CYTARABINE (CYTARABINE)
• METHYLPREDNISOLONE (methylprednisolone)
• Pixantrone (pixantrone)

Snippet

Sponsor: Theradex | Conditions: Lymphoma | Phase 2 | Status: UNKNOWN